company background image
EBO

EBOS Group NZSE:EBO Stock Report

Last Price

NZ$37.81

Market Cap

NZ$7.2b

7D

-5.3%

1Y

18.2%

Updated

03 Jul, 2022

Data

Company Financials +
EBO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends4/6

EBO Stock Overview

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand.

EBOS Group Competitors

Price History & Performance

Summary of all time highs, changes and price drops for EBOS Group
Historical stock prices
Current Share PriceNZ$37.81
52 Week HighNZ$44.30
52 Week LowNZ$30.80
Beta0.36
1 Month Change-6.37%
3 Month Change-6.64%
1 Year Change18.16%
3 Year Change60.21%
5 Year Change116.80%
Change since IPO1,566.12%

Recent News & Updates

Jun 24
Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

Slowing Rates Of Return At EBOS Group (NZSE:EBO) Leave Little Room For Excitement

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

May 10
An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

An Intrinsic Calculation For EBOS Group Limited (NZSE:EBO) Suggests It's 30% Undervalued

In this article we are going to estimate the intrinsic value of EBOS Group Limited ( NZSE:EBO ) by taking the expected...

Mar 17
Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

Return Trends At EBOS Group (NZSE:EBO) Aren't Appealing

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. In a perfect...

Feb 26
We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

We Think That There Are Issues Underlying EBOS Group's (NZSE:EBO) Earnings

EBOS Group Limited's ( NZSE:EBO ) robust earnings report didn't manage to move the market for its stock. Our analysis...

Feb 18
EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

EBOS Group (NZSE:EBO) Is Paying Out A Larger Dividend Than Last Year

EBOS Group Limited ( NZSE:EBO ) will increase its dividend on the 18th of March to NZ$0.49. Based on the announced...

Shareholder Returns

EBONZ HealthcareNZ Market
7D-5.3%-3.5%-0.2%
1Y18.2%-18.0%-18.5%

Return vs Industry: EBO exceeded the NZ Healthcare industry which returned -18% over the past year.

Return vs Market: EBO exceeded the NZ Market which returned -18.5% over the past year.

Price Volatility

Is EBO's price volatile compared to industry and market?
EBO volatility
EBO Average Weekly Movement3.5%
Healthcare Industry Average Movement4.1%
Market Average Movement4.5%
10% most volatile stocks in NZ Market8.3%
10% least volatile stocks in NZ Market3.0%

Stable Share Price: EBO is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: EBO's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19223,105John Cullityhttps://www.ebosgroup.com

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services.

EBOS Group Fundamentals Summary

How do EBOS Group's earnings and revenue compare to its market cap?
EBO fundamental statistics
Market CapAU$6.52b
Earnings (TTM)AU$194.30m
Revenue (TTM)AU$9.80b

33.6x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EBO income statement (TTM)
RevenueAU$9.80b
Cost of RevenueAU$8.73b
Gross ProfitAU$1.07b
Other ExpensesAU$876.43m
EarningsAU$194.30m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 24, 2022

Earnings per share (EPS)1.03
Gross Margin10.93%
Net Profit Margin1.98%
Debt/Equity Ratio13.1%

How did EBO perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

74%

Payout Ratio
We’ve recently updated our valuation analysis.

Valuation

Is EBO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EBO?

Other financial metrics that can be useful for relative valuation.

EBO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.7x
Enterprise Value/EBITDA19.2x
PEG Ratio2.2x

Price to Earnings Ratio vs Peers

How does EBO's PE Ratio compare to its peers?

EBO PE Ratio vs Peers
The above table shows the PE ratio for EBO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average11.4x
RYM Ryman Healthcare
6.3x-5.0%NZ$4.4b
SUM Summerset Group Holdings
4.1x-46.7%NZ$2.2b
FPH Fisher & Paykel Healthcare
29.9x7.9%NZ$11.3b
ARV Arvida Group
5.3x-37.3%NZ$1.0b
EBO EBOS Group
33.6x15.5%NZ$7.2b

Price-To-Earnings vs Peers: EBO is expensive based on its Price-To-Earnings Ratio (33.6x) compared to the peer average (11.4x).


Price to Earnings Ratio vs Industry

How does EBO's PE Ratio compare vs other companies in the Oceanian Healthcare Industry?

Price-To-Earnings vs Industry: EBO is expensive based on its Price-To-Earnings Ratio (33.6x) compared to the NZ Healthcare industry average (10.6x)


Price to Earnings Ratio vs Fair Ratio

What is EBO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EBO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio33.6x
Fair PE Ratio21.7x

Price-To-Earnings vs Fair Ratio: EBO is expensive based on its Price-To-Earnings Ratio (33.6x) compared to the estimated Fair Price-To-Earnings Ratio (21.7x).


Share Price vs Fair Value

What is the Fair Price of EBO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EBO (NZ$37.81) is trading below our estimate of fair value (NZ$64.76)

Significantly Below Fair Value: EBO is trading below fair value by more than 20%.


Price to Earnings Growth Ratio

PEG Ratio: EBO is poor value based on its PEG Ratio (2.2x)


Discover undervalued companies

Future Growth

How is EBOS Group forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


15.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EBO's forecast earnings growth (15.5% per year) is above the savings rate (2.1%).

Earnings vs Market: EBO's earnings (15.5% per year) are forecast to grow faster than the NZ market (6.6% per year).

High Growth Earnings: EBO's earnings are forecast to grow, but not significantly.

Revenue vs Market: EBO's revenue (5.9% per year) is forecast to grow slower than the NZ market (6.6% per year).

High Growth Revenue: EBO's revenue (5.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: EBO's Return on Equity is forecast to be low in 3 years time (13.4%).


Discover growth companies

Past Performance

How has EBOS Group performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


9.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: EBO has high quality earnings.

Growing Profit Margin: EBO's current net profit margins (2%) are higher than last year (1.9%).


Past Earnings Growth Analysis

Earnings Trend: EBO's earnings have grown by 9.6% per year over the past 5 years.

Accelerating Growth: EBO's earnings growth over the past year (11.9%) exceeds its 5-year average (9.6% per year).

Earnings vs Industry: EBO earnings growth over the past year (11.9%) underperformed the Healthcare industry 51.7%.


Return on Equity

High ROE: EBO's Return on Equity (9.3%) is considered low.


Discover strong past performing companies

Financial Health

How is EBOS Group's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: EBO's short term assets (A$2.7B) exceed its short term liabilities (A$2.0B).

Long Term Liabilities: EBO's short term assets (A$2.7B) exceed its long term liabilities (A$634.5M).


Debt to Equity History and Analysis

Debt Level: EBO has more cash than its total debt.

Reducing Debt: EBO's debt to equity ratio has reduced from 41.5% to 13.1% over the past 5 years.

Debt Coverage: EBO's debt is well covered by operating cash flow (113%).

Interest Coverage: EBO's interest payments on its debt are well covered by EBIT (11.2x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is EBOS Group current dividend yield, its reliability and sustainability?

Dividend Score

4/6

Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


2.47%

Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: EBO's dividend (2.47%) isn’t notable compared to the bottom 25% of dividend payers in the NZ market (3.09%).

High Dividend: EBO's dividend (2.47%) is low compared to the top 25% of dividend payers in the NZ market (6.15%).


Stability and Growth of Payments

Stable Dividend: EBO's dividends per share have been stable in the past 10 years.

Growing Dividend: EBO's dividend payments have increased over the past 10 years.


Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (73.6%), EBO's dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: At its current cash payout ratio (84.9%), EBO's dividend payments are covered by cash flows.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.4yrs

Average management tenure


CEO

John Cullity

4.25yrs

Tenure

AU$3,700,000

Compensation

Mr. John Cullity has been Non-Executive Director of Terry White Group Limited since March 29, 2018. Mr. Cullity has been Chief Executive Officer of EBOS Group Limited since April 1, 2018. Mr. Cullity serve...


CEO Compensation Analysis

Compensation vs Market: John's total compensation ($USD2.51M) is above average for companies of similar size in the NZ market ($USD1.85M).

Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: EBO's management team is considered experienced (4.4 years average tenure).


Board Members

Experienced Board: EBO's board of directors are considered experienced (9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.8%.


Top Shareholders

Company Information

EBOS Group Limited's employee growth, exchange listings and data sources


Key Information

  • Name: EBOS Group Limited
  • Ticker: EBO
  • Exchange: NZSE
  • Founded: 1922
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Implied Market Cap: NZ$7.161b
  • Shares outstanding: 189.38m
  • Website: https://www.ebosgroup.com

Number of Employees


Location

  • EBOS Group Limited
  • 737 Bourke Street
  • Level 7
  • Docklands
  • Victoria
  • 3008
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/07/03 00:00
End of Day Share Price2022/07/01 00:00
Earnings2021/12/31
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.